Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm A Smith

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|June 18, 2011
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing ProgramPeter J Houghton, Min H Kang, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|June 27, 2013
Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing programAndrew C Wood, John M Maris, Richard Gorlick, et al.
Pediatric Blood & Cancer|December 18, 2009
Initial testing of topotecan by the pediatric preclinical testing programHernan Carol, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|November 22, 2011
Testing of the Akt/PKB inhibitor MK-2206 by the Pediatric Preclinical Testing ProgramRichard Gorlick, John M Maris, Peter J Houghton, et al.
Pediatric Blood & Cancer|October 27, 2009
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|August 27, 2010
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing programHernan Carol, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|August 20, 2013
Initial testing (stage 1) of the Polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing ProgramRichard Gorlick, E Anders Kolb, Stephen T Keir, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing of lenalidomide by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, Stephen T Keir, et al.
Pediatric Blood & Cancer|September 25, 2012
Initial testing (stage 1) of the phosphatidylinositol 3' kinase inhibitor, SAR245408 (XL147) by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, Hernan Carol, et al.
Pediatric Blood & Cancer|November 20, 2014
Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Stephen T Keir, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|June 18, 2011
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing ProgramPeter J Houghton, Min H Kang, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|June 27, 2013
Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing programAndrew C Wood, John M Maris, Richard Gorlick, et al.
Pediatric Blood & Cancer|December 18, 2009
Initial testing of topotecan by the pediatric preclinical testing programHernan Carol, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|November 22, 2011
Testing of the Akt/PKB inhibitor MK-2206 by the Pediatric Preclinical Testing ProgramRichard Gorlick, John M Maris, Peter J Houghton, et al.
Pediatric Blood & Cancer|October 27, 2009
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|August 27, 2010
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing programHernan Carol, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|August 20, 2013
Initial testing (stage 1) of the Polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing ProgramRichard Gorlick, E Anders Kolb, Stephen T Keir, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing of lenalidomide by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, Stephen T Keir, et al.
Pediatric Blood & Cancer|September 25, 2012
Initial testing (stage 1) of the phosphatidylinositol 3' kinase inhibitor, SAR245408 (XL147) by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, Hernan Carol, et al.
Pediatric Blood & Cancer|November 20, 2014
Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Stephen T Keir, et al.
Pageof 19